REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanli Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Sanli Ilac Sanayi Anonim Sirketi Profile Updated: March 28, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Şanlı İlaç Sanayi A.Ş is a pharmaceutical company that specializes in the production of traditional herbal medical products and plasters. Their product line includes a variety of medications such as analgesic, anti-inflammatory, antirheumatic, antihyperuricemic, glucocorticoid, and vitamins in tablet, suspension, pomade, and syrup forms. They have also developed a natural and herbal ingredient topical application called "Şanlı Kapsikumlu Delikli Yakı", also known as the Lion Plaster. Şanlı İlaç has expanded its operations to foreign markets, with distributorships in 8 countries and ongoing operations in 6 countries.

Headquarters
Sanli Apartmani No:6-0 Aosb Mahallesi 10046 Sokak Cigli
Izmir; Aegean; Postal Code: 35620

Contact Details: Purchase the Sanli Ilac A.S. report to view the information.

Website: http://www.sanliilac.com.tr

Basic Information
Total Employees:
Purchase the Sanli Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Sanli Ilac A.S. report to view the information.
Incorporation Date:
April 19, 1951
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Sanli Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
-3.25%
Total operating revenue
-3.25%
Operating profit (EBIT)
20.78%
Net Profit (Loss) for the Period
20.78%
Total assets
15.89%
Total equity
41.62%
Operating Profit Margin (ROS)
6.62%
Net Profit Margin
6.62%
Return on Equity (ROE)
-7.85%
Debt to Equity Ratio
-7.3%
Quick Ratio
0.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?